Astrazeneca Pharma India Ltd.

Financial

	Astrazeneca Pharma I	Fortis Healthcare	Artemis Medicare
Operational Metrics
Pharmaceutical Sector
Domestic Sales Growth - YoY	18.6 %	n/a	n/a
R&D as a % of Total Sales	0.0	n/a	n/a
Financials
5 yr Average ROE	17.46 %	2.33 %	6.75 %
5yr average Equity Multiplier	1.97	1.73	2.0
5yr Average Asset Turnover Ratio	0.99	0.44	0.83
5yr Avg Net Profit Margin	9.04 %	2.18 %	3.96 %
Price to Book	20.67	4.4	6.0
P/E	97.19	60.61	55.52
5yr Avg Cash Conversion Cycle	-120.04 Days	-133.71 Days	-93.73 Days
Inventory Days	63.93 Days	6.17 Days	6.64 Days
Days Receivable	35.03 Days	31.7 Days	41.25 Days
Days Payable	229.92 Days	220.67 Days	147.42 Days
5yr Average Interest Coverage Ratio	104.17	3.83	3.4
5yr Avg ROCE	23.44 %	4.56 %	8.87 %
5yr Avg Operating Profit Margin	15.59 %	14.05 %	12.04 %
5 yr average Debt to Equity	0.0	0.19	0.44
5yr CAGR Net Profit	12.77 %	n/a	13.5 %
5yr Average Return on Assets	8.84 %	1.32 %	3.34 %
Shareholdings
Promoter Holding	75.0 %	31.17 %	68.03 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.0	-1.79 %
Change in Mutual Fund Holding (3 Yrs)	2.92 %	14.26 %	0.79 %

Business

	Astrazeneca Pharma I	Fortis Healthcare	Artemis Medicare
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 93.9 Clinical Trial 6.1 Out-Patient Services 0 In-Patient Services 0 0 0	Product Wise Break-Up 0 Pharmaceutical 0 Clinical Trial 0 Out-Patient Services 13.51 0 In-Patient Services 85.57 Others 0.92	Product Wise Break-Up Pharmaceutical 2.05 Pharmaceutical 0 Clinical Trial 0 Out-Patient Services 0 Healthcare 97.61 In-Patient Services 0 Others 0.34
Location Wise Break-Up	Location Wise Break-Up India 93.61 Rest of the World 6.39 South India 0 East India 0 West India 0 North India 0 International 0 Domestic 0	Location Wise Break-Up North India 34.0 Rest of the World 3.0 India 0 International 0 Domestic 0 West India 21.0 South India 28.0 East India 14.0	Location Wise Break-Up North India 0 Rest of the World 0 India 0 International 26.57 Domestic 73.43 West India 0 South India 0 East India 0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Oncology 55.8 Cardiac Science 27.0 Anti - Diabetes 13.7 Respiratory Systems 3.5 Gastrointestinal 0 Infection 0	-	Therapeutic Area Break-Up Gastrointestinal 0 Respiratory Systems 0 Anti - Diabetes 0 Cardiac Science 0 Oncology 19.0 Infection 0 Others 81.0
Dosage Form Break-Up	Dosage Form Break-Up Tablet 75.21 Injectable 16.69 Clinical Trial 6.1 Inhalation 2.0	-	-